To the Editor:
In a recent issue of the American Journal of Respiratory and Critical Care Medicine, Prasad and colleagues eloquently consolidated the bidirectional interaction between asthma and obstructive sleep apnea (OSA) (1) . However, in order to develop a personalized approach towards comorbid pulmonary diseases, with systemic spill over of inflammation (1) , we have to maintain intentionality in appreciating their cardiovascular interactions (2) . Since the cardiovascular impact of OSA and chronic obstructive pulmonary disease (COPD) is relatively well described (2), a brief discussion with regards to asthma and cardiovascular disease (CVD) is warranted.
A recent large retrospective cohort of patients admitted to National Health Service hospitals in the United Kingdom reported the strong and independent association of asthma, COPD, and interstitial lung disease with CVD (4). Asthma was independently associated with ischemic heart disease (4), while heart failure (hazard ratio: 1.81; 95% confidence interval: 1.75 to 1.87) and ischemic heart disease (hazard ratio: 1.04; 95% confidence interval: 1.01 to 1.07) were amongst the variables independently associated with mortality in asthmatics (3) . In another large study, late-onset asthma, diagnosed at age 18 yrs or older, was associated with an increased risk of incident CVD events after adjustment for age, sex, and CVD risk factors (4) . In a biracial, community-based, long-term investigation of risk factors and natural history of CVD, young adults with a history of asthma were at a significantly greater risk of increased left ventricular mass index, independent of other major cardiovascular risk factors (5) .
Many similarities exist between biochemical and cellular pathways of cardiac and pulmonary fibrosis (6) . As we read the article by Prasad and colleagues and appreciate the multifaceted overlap of asthma and OSA (1), we have to remind ourselves of the current evidence and
